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Abstract 
Histoplasma capsulatum is a dimorphic fungal pathogen endemic to the Ohio River 
valley. This pathogen is particularly harmful because of its ability to cause disease in both 
immunocompromised and immunocompetent hosts. Histoplasma primarily affects the 
respiratory system, leading to colonization of the lungs, but can disseminate to other organs such 
as the spleen and bone marrow. The mechanisms of Histoplasma virulence and how it adapts to 
growth within host cells and the host environment are relatively unknown. We have isolated a 
strain of H. capsulatum with a mutation in the DSC2 gene, which is postulated to regulate the 
fungal response to hypoxia. The Dsc complex responds to decreased sterol synthesis, which is 
coupled to decreased oxygen levels. We hypothesize that the Dsc complex may allow 
Histoplasma to survive in the potential hypoxic environments of different organs. To test this, we 
developed a complemented strain and analyzed the ability of the wild-type, the dsc2 mutant, and 
complemented strains to grow under low oxygen, conditions that mimic hypoxia in vitro (e.g., 
growth with CoCl2), and infection of cultured macrophages. The data obtained showed some 
indication of decreased survival of the dsc2 mutant in comparison with the wild-type and 
complemented strains. We also examined the progression of disease of the dsc2 mutant strain in 
vivo using a murine model of respiratory and disseminated histoplasmosis. A better 
understanding of Histoplasma virulence mechanisms such as the response to hypoxia could help 
to indicate new targets for potential therapeutics for histoplasmosis. 
Introduction 
 Histoplasma capsulatum is a fungal pathogen that is particularly prevalent in the Ohio 
and Mississippi river valleys. It is a dimorphic fungus, existing as filamentous mycelia in lower 
temperature environments and infectious yeasts at 37˚ (1). Histoplasma initially infects the lungs, 
which means the conidia are inhaled and then convert to yeasts due to the increased temperature 
of the body. Within the lungs, Histoplasma proliferates in macrophages and can disseminate to 
other areas of the body. Histoplasma causes the disease histoplasmosis which ranges from 
subclinical symptoms to life-threatening disseminated disease (2). It is particularly unique among 
fungal pathogens because of its ability to cause disease in both immunocompromised and 
immunocompetent hosts. In hosts with a healthy immune system, Histoplasma may only cause a 
mild or asymptomatic infection. In patients who do not possess a fully functioning immune 
system, however, it may manifest in more severe forms, including possible dissemination (2).  
 During infection of the lungs, Histoplasma must combat many host factors in order to 
survive and replicate to become a persistent infection. Histoplasma faces obstacles from the 
immune system including phagocytosis and antimicrobial reactive oxygen species produced by 
immune cells.  In addition, it may experience conditions of hypoxia in the lung.  While the lung 
is normally a highly oxygenated tissue, formations of large masses of cells such as infiltrating 
neutorophils and other inflammatory cells can decrease the oxygen availability (3, 6). 
 One potential way that Histoplasma may survive in these hypoxic environments is 
through adaptation to hypoxia which is controlled by a protein complex called Dsc. In 
Aspergillus fumigatus, another fungal pathogen, it has been shown that Dsc is necessary for 
survival in hypoxia (4). As Histoplasma is also a pathogen of mammalian lungs, Dsc may also 
facilitate Histoplasma infection. To test this hypothesis, I am investigating the gene DSC2, which 
forms part of the Dsc complex. In the proposed mechanism of action, Dsc recognizes low 
oxygen levels and then cleaves the N-terminal helix-loop-helix motif of the protein Srb1. This 
Srb1 cleavage product is then transported to the nucleus where it acts as a transcription factor for 
genes that regulate Histoplasma’s response to hypoxia. The loss of Dsc2 would thus result in 
decreased cleavage of Srb1 in response to hypoxia which would lead to an inability to produce 
the active transcription factor needed to initiate the hypoxia response. 
Materials and Methods 
Strains and growth conditions 
The dsc2 mutant strain OSU152 was created previously using transposon mutagenesis in 
a uracil auxotroph background. To generate uracil prototrophs for use in infections, this strain 
was then transformed with plasmid pCR628 which expresses the URA5 gene. The dsc2 
complemented strain, OSU213, was created by transforming the dsc2 mutant strain with a 
plasmid containing the wild-type DSC2 gene.  
Strains were grown at 37° on Histoplasma-macrophage media (HMM, 5). Liquid cultures 
were grown up to late exponential/early stationary phase with continuous shaking of the cultures 
at 200 rpm.  
CoCl2 assay 
CoCl2 was used to mimic hypoxia conditions. Wild-type, mutant, and complemented 
strains were grown in 96-well plates with variable concentrations of CoCl2. Growth of 
Histoplasma yeasts over time was monitored by OD595 on a Synergy 2 plate reader (BioTek). 
Growth at normoxic, hypoxic, and anaerobic conditions 
Liquid cultures of the wild type, mutant, and complemented strains were grown to late 
exponential/early stationary phase and the yeasts suspension enumerated by hemacytometer.  
Equivalent concentrations of yeasts were spotted on HMM plates in triplicate. Plates were stored 
in a normal incubator (approx. 20% O2), a hypoxic incubator (0.5% O2, 5% CO2, 94.5% N2), and 
in an anaerobic chamber flushed with N2. Yeasts were incubated at 37° until growth was 
observed. 
Macrophage assay 
P388D1 macrophages were seeded in a 96-well plate at 2 x 10
4
 cells/well in complete 
F12 media (Ham’s F12, 10% FBS, L-glutamine, 10 µg/mL tetracycline, 20 µg/mL gentamycin), 
and left to adhere at 37° for 24 hours prior to infection. During infection, 2 x 10
4 
Histoplasma 
yeasts were added to the wells in HMM-M complete (HMM-M, 10% FBS, L-glutamine, 10 
µg/mL tetracycline, 20 µg/mL gentamycin). After 4 hours, the media was removed and replaced 
with fresh media. Intracellular survival and replication of yeasts was determined by plating of 
macrophage lysates.  For plating, every 24 hours macrophages were lysed with sterile TE buffer 
(10 mMTris, pH 8.0, 1 mM EDTA, pH 8.0) and dilutions of the lysate plated on HMM to 
determine viable colony forming units. Plates were grown at 37°, 5% CO2/95% air. 
In vivo competition assay 
 For competition assays, wild type was marked with red-fluorescent protein, the dsc2 
mutant with green-fluorescent protein, and the dsc2/DSC2 complemented strain as non-
fluorescent.  Yeasts for inoculation of mice were counted by hemacytometer. Each C57BL/6 
mouse was infected intranasally with 3 x 10
4
 yeasts in a volume of 45 microliters. At four day 
intervals post infection (4, 8, 12, 16, and 20 days), mice were euthanized and the lungs and 
spleens were removed and homogenized in 5 mL and 3 mL HMM, respectively. Dilutions of 
homogenates were plated on HMM to determine viable colony-forming units (cfu) in each tissue. 
Strain genotypes were inferred using red, green, or non-fluorescence of colonies as measured 
with a UV transilluminator with appropriate filters for GFP and RFP fluorescence emission.  
 
Construction of SRB1-RNAi strain 
An SRB1-RNA interference (RNAi) strain was created to knockdown expression of 
SRB1. A fragment of the SRB1 coding sequence was cloned into an RNAi vector with a GFP 
sentinel to provide a visual indicator of target gene knock-down. In the RNAI vector, two copies 
of the gene fragment are inserted in reverse orientation to create an RNA hairpin after 
transcription. The hairpin is cleaved by Histoplasma proteins and then the RNA fragments 
induce the cleavage of the corresponding gene in the cell. The GFP gene can be included in the 
hairpin, which will then act in trans to knock-down GFP fluorescence in the cell.  The SRB1-
RNAi plasmid was transformed into Agrobacterium tumefaciens by electroporation to enable 
Agrobacterium-mediated transformation of Histoplasma. Agrobacterium was cocultured with 
Histoplasma strain OSU194 (a GFP fluorescent wild type background) to induce uptake and 
integration of the plasmid DNA, and knock-down of GFP fluorescence of transformant colonies 
tested. Histoplasma strain OSU194 with gfp-RNAi plasmid pED02 (lacking sequences for SRB1 
knock-down) was used as the control. 
Results 
dsc2 mutant is more susceptible to effects of CoCl2 
As an in vitro test of sensitivity to hypoxia, yeasts were treated with CoCl2 which mimics 
many of the aspects of growth in low oxygen.  A graded series of CoCl2 concentrations were 
tested to establish a dose-response curve (Figure 1).  Whereas the wild-type had an IC50 of 0.45 
mM, the dsc2 mutant showed increased sensitivity to CoCl2 with an IC50 of 0.034 mM. 
Complementation of the dsc2 mutation restored the resistance of Histoplasma yeast to CoCl2 
with an IC50 of 0.38 mM.  This shows that (1) the dsc2 mutation is more sensitive to CoCl2 
treatment and (2) complementation of the dsc2 mutation reveals the sensitivity is directly linked 
to the loss of Dsc function.  Since CoCl2 mimics many of the aspects of hypoxia, we infer that 
Dsc functions to facilitate growth of Histoplasma yeasts in low oxygen environments. 
 
 
Figure 1: Effects of [CoCl2] on Histoplasma capsulatum DSC2 (WU15), dsc2 (OSU152), and 
dsc2/DSC2 (OSU213) strains. 
 
Growth of dsc2 mutant is attenuated under lower oxygen conditions 
As a more direct test of the sensitivity of Histoplasma yeast to hypoxia, wild-type and 
dsc2-mutant yeasts were grown under hypoxic and anaerobic conditions.  In normoxia, the wild-
type and the dsc2 mutant produced similarly sized colonies after 7 days of incubation (Figure 
2A).  In hypoxia (0.5% oxygen), growth rate was significantly reduced (data not shown) but 
wild-type and dsc2-mutant strains grew similarly (Figure 2B).  In more severe reduction of 
oxygen, the dsc2 mutant showed greater impairment in growth than the wild-type and the 
dsc2/DSC2 complemented strain (Figure 2C).  The dsc2 mutant was not impaired in the number 
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of colonies formed, but instead in the size of the colonies, indicating viability was not impaired 
but growth was significantly reduced.  These data confirm the CoCl2 tests and indicate that DSC2 
is involved in maintaining normal growth in very low oxygen conditions.  
  
 
 
  
 
 
Figure 2A:  Growth under normoxic conditions (approximately 20% O2) 2B-C: Growth under 
hypoxic (0.5% O2) and anaerobic (0% O2) conditions. 
 
Dsc2 is necessary for intramacrophage growth 
Since the host cell for Histoplasma is the alveolar macrophage, we tested whether dsc2 
(and thus adaptation to hypoxia) was required for growth in macrophages using the P388D1 
macrophage cell line.  Macrophage cells were infected with wild-type, dsc2-mutant, and 
dsc2/DSC2 yeasts at a multiplicity of infection of 0.5 yeasts/macrophage.  At incremental time 
points, the number of yeasts was quantified by lysing the macrophages and plating of the lysate 
for viable colony forming units.  The wild-type and dsc2/DSC2 strain both survived and 
replicated in macrophages similarly, increasing 30-fold by 48 hours.  In contrast, the dsc2 mutant 
showed only 15-fold increase in cell number indicating the ability to replicate in macrophages is 
attenuated with Dsc2 function (Figure 3). 
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Figure 3: Survival of Histoplasma wild-type, dsc2 mutant, and dsc2/DSC2 complemented 
strains in P388D1 macrophage cell line. 
 
Dsc2 is not required for infection in vivo 
To determine whether Histoplasma yeasts must adapt to hypoxia in vivo, mice were co-
infected with equal amounts of the wild-type, dsc2 mutant, and complemented strains. This 
competition assay is a sensitive measure of whether Dsc2 confers a fitness advantage in vivo.  
After 8 days, the fungal burden in lungs and in spleens was determined as indicators of acute 
respiratory infection and dissemination capability, respectively.  Colony counts of the strains 
indicated that there was no significant difference in infection of the lungs nor in spleens of the 
mice at day 8 (Figure 4). This trend also continued throughout the course of the infection (data 
not shown). This indicates that Dsc2 may not be required for infection in mice.  
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Figure 4: Competition assay to examine the relative fitness of the wild-type, dsc2 mutant, and 
complemented strains in vivo. 
 
Srb1 is required in Histoplasma 
We sought to determine if the downstream effector of Dsc activation was involved and so 
SRB1 expression was targeted for knocked down by RNAi (Figure 5). Unfortunately, no 
transformants were recovered that had knock-down of the gfp sentinel. Conversely, this indicated 
that there was no knock-down of the SRB1 gene. This was in contrast to transformation with an 
RNAi plasmid lacking the SRB1 sequences.  This data indicates that no viable transformants 
with SRB1-knock down were obtained which strongly suggests that knock-down of SRB1 is 
lethal to the yeasts. 
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Figure 5: Use of RNA interference (RNAi) to observe knock-down of the Histoplasma SRB1 
gene. 
 
Discussion 
This study shows that DSC2 is required by Histoplasma for growth under low oxygen in 
vitro. These findings are similar to those of the fungal pathogen Aspergillus fumigatus (4), which 
indicates that the mode of action of Dsc may be similar in both organisms. In the CoCl2 assay, 
there was approximately a 15-fold decrease in IC50 of the dsc2 mutant compared to wild type. 
This is reflected when the strains were grown on under very low oxygen conditions. There was 
attenuation in colony size rather than colony number which means it may be possible for 
Histoplasma to establish growth in hypoxic conditions, but not to maintain it. The plates with 
Histoplasma spots were not prepared under hypoxic conditions, so any remaining oxygen in the 
media may have been enough to begin growth of the dsc2 mutant because the strains were not 
gfp-RNAi 
transformants 
gfp:SRB1-RNAi 
transformants 
immediately under hypoxic conditions. This is unlikely, however, due to the greater amounts of 
time it takes Histoplasma to begin to grow.  
When measuring survival and proliferation of the Histoplasma yeasts in macrophages, 
intramacrophage survival was decreased 20-fold in the dsc2 mutant compared to wild type. This 
indicates that intracellular proliferation requires Dsc2 in Histoplasma. All three Histoplasma 
strains were phagocytized equally by the macrophages, but dsc2 mutant yeasts were unable to 
replicate as efficiently as wild type. This indicates that the deficiency is due to loss of Dsc2-
dependent adaptation to the intracellular environment.  Given these results, it was surprising that 
in vivo infection showed no requirement for Dsc2.  This fact that Dsc2 is dispensable suggests 
that in vivo, Histoplasma does not encounter significant hypoxic conditions. This could be due to 
the possibility that the mice lungs are not as hypoxic as other animals, although work with 
pulmonary Aspergillus infections indicates some hypoxia is created within the lung (4).  
However, Aspergillus evokes a profound inflammatory response whereas Histoplasma yeasts 
reside within immune cells and do not stimulate as much activation.  In longer term infections, 
Histoplasma yeasts trigger granuloma formation (an organized immune response designed to 
“wall-off” the infection) and these granulomas can become calcified.  This granuloma 
environment can become significantly hypoxic (6) so it would be interesting to see if Dsc2 is 
required for long-term infections in mammals. 
Although we were able to successfully mutate DSC2, we were unable to interfere with 
the function of the downstream effector Srb1.  Our results using a gfp-sentinel strain suggests 
that Srb1 is essential.  This indicates that Dsc2-dependent Srb1 activation is likely only part of 
the upstream inputs into Srb1.  Srb1 has also been proposed to function in the production of 
responses to iron limitation which would be essential. Additional testing to determine the 
presence of an Srb1 cleavage product and localizing Srb1 in the cells would be beneficial in 
further characterization of Dsc2 and its interactions with Srb1 in Histoplasma. 
Our results with Dsc2 suggest that Histoplasma does not encounter significant hypoxia in 
vivo, at least in acute disease.  Future experiments addressing the role of Dsc2, and thus 
adaptation to hypoxia, in establishment of latent infections will be needed to determine if 
targeting hypoxia response pathways could be a viable therapeutic option. 
 
Superoxide dismutase (SOD3) 
 As a supplement to my work on DSC2, I have also been working on comparing the roles 
of superoxide dismutase (SOD3) in two divergent Histoplasma strains, G186A and G217B. 
Histoplasma secrets the superoxide dismutase Sod3 in order to help protect itself from 
extracellular reactive oxygen species (ROS) produced by the host cells that combat the fungal 
infection. Superoxide is a type of ROS produced by the host which is broken down by 
superoxide dismutase. The mechanisms of Sod3 virulence have been characterized in the G186A 
strain previously (7), but the comparison has not been made between G186A and G217B. G217B 
has greater virulence than G186A in mice and one potential mechanism is greater resistance to 
host-produced superoxide.  To test this idea, we have created mutant strains in both backgrounds 
G186A and G217B, respectively. I constructed complemented strains for each background by 
cloning the wild-type SOD3 gene into Agrobacterium vector pCR639 and transforming the 
resulting plasmids (pED07 and pED08 for G186A and G217B, respectively) into Histoplasma 
via Agrobacterium. These plasmids are then integrated into the recipient cell DNA. Cell cultures 
were grown in HMM liquid media and supernatants were isolated from the cultures by spinning 
the cells down at 2000 rcf for 2 minutes and then filter sterilizing the supernatant with 0.2 µm 
pore polyethersulfone (PES) membranes. A portion of the culture filtrates was concentrated 
using acetone precipitation and then run on a polyacrylamide gel. The proteins were transferred 
to a nitrocellulose membrane for immunoblotting with α-Sod3 antibody in order to confirm the 
construction of the mutant and complemented of the mutation. As expected, Sod3 protein was 
not present in the mutant strains (Figure 6) but was produced by the wild-type parent and the 
sod3/SOD3 complemented lines. With confirmed strains, we can now test the relative 
contribution of Sod3 to the virulence of G186A and G217B. 
 
 
 
 
 
 
 
  
Figure 6: Immunoblot with α-Sod3 antibody of wild-type, sod3 mutant, and two complemented 
strain isolates for each Histoplasma background. 
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